跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 44 条关于
“TRPV4”
全部
44
临床试验
20
药物
15
机构
0
资讯
9
去年
First Patient Dosed in Phase 1 Trial of ABS-0871 for Charcot-Marie-Tooth Disease 2C Treatment
去年
Actio Biosciences Raises $66M Series B to Advance Rare Disease Programs Targeting Ion Channel Disorders
2年前
South Rampart Pharma's SRP-001 Shows Promise as Non-Opioid Pain Treatment in Phase 1 Trial
上个月
Jazz Pharmaceuticals to Acquire Actio Biosciences for $820 Million, Securing First-in-Class KCNT1 Epilepsy Therapy ABS-1230
11个月前
PILA PHARMA Partners with Gubra for Preclinical Obesity Trials of TRPV1 Inhibitor XEN-D0501
3个月前
Pila Pharma Receives EMA Go-Ahead to Start Obesity Trials for TRPV1 Antagonist XEN-D0501
2个月前
Ellison Medical Institute and UniQuest Partner to Advance First-in-Class TRPV6-Targeting Therapy for Resistant Prostate Cancer
去年
Kamari Pharma Secures $23 Million Series A to Advance First-in-Class TRPV3 Inhibitor for Rare Genetic Skin Diseases
5个月前
Orvida Pharma Reports Positive Phase 1a Safety Data for KM-023, First-in-Class TRPV3 Inhibitor for Olmsted Syndrome
